ONCOMEMBRANE INC has a total of 12 patent applications. Its first patent ever was published in 1991. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are BIOTIE THERAPIES OYJ, A1M PHARMA AB and WOMENS & CHILDRENS HOSPITAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | Canada | 2 | |
#4 | Japan | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Unspecified technologies | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Igarashi Yasuyuki | 11 |
#2 | Hakomori Sen-Itiroh | 11 |
#3 | Ohta Hideki | 4 |
#4 | Yatomi Yutaka | 4 |
#5 | Ruan Fuqiang | 2 |
#6 | Sadozai Khalid | 2 |
#7 | Nudelman Edward | 2 |
#8 | Park Yong S | 1 |
#9 | Okoshi Hirofumi | 1 |
#10 | Handa Kazuko | 1 |
Publication | Filing date | Title |
---|---|---|
US5677189A | Method for quantifying sphingosine and for diagnosing platelet activation | |
US5693620A | Plasmalopsychosines and plasmalocerebrosides | |
US5627171A | Sphingosine-1-phosphate/trimethylsphingosine composition |